BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32927341)

  • 1. Self-reported benefit and weakness after botulinum toxin in dystonia.
    Kassavetis P; Lungu C; Ehrlich D; Alter K; Karp BI
    Parkinsonism Relat Disord; 2020 Nov; 80():10-11. PubMed ID: 32927341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum Toxin Effects on Sensorimotor Integration in Focal Dystonias.
    De Bartolo MI; Manzo N; Ferrazzano G; Baione V; Belvisi D; Fabbrini G; Berardelli A; Conte A
    Toxins (Basel); 2020 Apr; 12(5):. PubMed ID: 32344856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Botulinum toxin therapy for focal dystonia].
    Hahn K; Niklai E; Garzuly F; Szupera Z
    Orv Hetil; 2009 Jul; 150(29):1381-4. PubMed ID: 19581172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Focal or Segmental Dystonia Resistant to Botulinum Toxin: How Do You Treat Patients in Whom Botulinum Toxin Treatment Has No Effect?].
    Nomura T
    Brain Nerve; 2022 May; 74(5):581-587. PubMed ID: 35589651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum A toxin injection in patients with blepharospasm, torticollis and hemifacial spasm.
    Berardelli A; Carta A; Stocchi F; Formica A; Agnoli A; Manfredi M
    Ital J Neurol Sci; 1990 Dec; 11(6):589-93. PubMed ID: 2081684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54 Suppl 3():44-51. PubMed ID: 1810208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54(5):210-7. PubMed ID: 1804035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contributions and limitations for botulinum toxin injections for extrapyramidal diseases].
    Hinault P
    Rev Neurol (Paris); 2000 Dec; 156(12):1171-7. PubMed ID: 11139738
    [No Abstract]   [Full Text] [Related]  

  • 10. [Botulin in the treatment of local dystonia].
    Domzał T
    Neurol Neurochir Pol; 1992; 26(6):783-9. PubMed ID: 1301505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm.
    Albanese A; Colosimo C; Carretta D; Dickmann A; Bentivoglio AR; Tonali P
    Eur Neurol; 1992; 32(2):112-7. PubMed ID: 1563461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin injections reduce associative plasticity in patients with primary dystonia.
    Kojovic M; Caronni A; Bologna M; Rothwell JC; Bhatia KP; Edwards MJ
    Mov Disord; 2011 Jun; 26(7):1282-9. PubMed ID: 21469207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatiotemporal Gait Differences before and after Botulinum Toxin in People with Focal Dystonia: A Pilot Study.
    Cuinat J; Debû B; Meoni S; Pelissier P; Castrioto A; Fraix V; Moro E
    Mov Disord Clin Pract; 2024 Feb; 11(2):143-151. PubMed ID: 38386480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm.
    Karp BI; Alter K
    Semin Neurol; 2016 Feb; 36(1):84-91. PubMed ID: 26866500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new botulinum toxin (Xeomin) for cervical dystonia and blepharospasm.
    Med Lett Drugs Ther; 2010 Nov; 52(1351):90-1. PubMed ID: 21068703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Craniocervical dystonia: clinical and pathophysiological features.
    Colosimo C; Suppa A; Fabbrini G; Bologna M; Berardelli A
    Eur J Neurol; 2010 Jul; 17 Suppl 1():15-21. PubMed ID: 20590803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Focal dystonias and their treatment with dysport (botulinum toxin type A)].
    Orlova OR; Timerbaeva SL; Khat'kova SE; Kotliarov VV; Korenko LA; Zalialova ZA; Fal'kovskiĭ IV; Shperling LP; Antipova LN; Antipenko EA; Mingazova LR; Soĭkher MI; Krasavina DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5):81-9. PubMed ID: 22951787
    [No Abstract]   [Full Text] [Related]  

  • 18. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
    Brin MF; Fahn S; Moskowitz C; Friedman A; Shale HM; Greene PE; Blitzer A; List T; Lange D; Lovelace RE
    Mov Disord; 1987; 2(4):237-54. PubMed ID: 3504553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects.
    Dutton JJ
    Surv Ophthalmol; 1996; 41(1):51-65. PubMed ID: 8827930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins.
    Hassell TJW; Charles D
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32331272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.